Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis

A wound is a type of injury that damages living tissues. In this review, we will be referring mainly to healing responses in the organs including skin and the lungs. Fibrosis is a process of dysregulated extracellular matrix (ECM) production that leads to a dense and functionally abnormal connective tissue compartment (dermis). In tissues such as the skin, the repair of the dermis after wounding requires not only the fibroblasts that produce the ECM molecules, but also the overlying epithelial layer (keratinocytes), the endothelial cells, and smooth muscle cells of the blood vessel and white blood cells such as neutrophils and macrophages, which together orchestrate the cytokine-mediated signaling and paracrine interactions that are required to regulate the proper extent and timing of the repair process. This review will focus on the importance of extracellular molecules in the microenvironment, primarily the proteoglycans and glycosaminoglycan hyaluronan, and their roles in wound healing. First, we will briefly summarize the physiological, cellular, and biochemical elements of wound healing, including the importance of cytokine cross-talk between cell types. Second, we will discuss the role of proteoglycans and hyaluronan in regulating these processes. Finally, approaches that utilize these concepts as potential therapies for fibrosis are discussed.

[1]  R. Hull,et al.  Hyaluronan , 2015, Biology of Extracellular Matrix.

[2]  Swati Pradhan-Bhatt,et al.  Hyaluronan: a simple polysaccharide with diverse biological functions. , 2014, Acta biomaterialia.

[3]  D. Vigetti,et al.  Metabolic control of hyaluronan synthases. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[4]  G. Hart,et al.  The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[5]  R. Markwald,et al.  Overexpression of c-Met and CD44v6 Receptors Contributes to Autocrine TGF-β1 Signaling in Interstitial Lung Disease* , 2014, The Journal of Biological Chemistry.

[6]  R. Levine,et al.  Periostin Induces Intracellular Cross-talk between Kinases and Hyaluronan in Atrioventricular Valvulogenesis* , 2014, The Journal of Biological Chemistry.

[7]  K. Venkateswara Swamy,et al.  Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells. , 2013, Bioorganic & medicinal chemistry.

[8]  A. Phillips,et al.  Transforming Growth Factor-β1 (TGF-β1)-stimulated Fibroblast to Myofibroblast Differentiation Is Mediated by Hyaluronan (HA)-facilitated Epidermal Growth Factor Receptor (EGFR) and CD44 Co-localization in Lipid Rafts* , 2013, The Journal of Biological Chemistry.

[9]  E. Harris,et al.  The Hyaluronan Receptor for Endocytosis (HARE) Activates NF-κB-mediated Gene Expression in Response to 40–400-kDa, but Not Smaller or Larger, Hyaluronans* , 2013, The Journal of Biological Chemistry.

[10]  Yoshinori Sugiyama,et al.  KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization , 2013, Proceedings of the National Academy of Sciences.

[11]  Hui Liu,et al.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. , 2013, The Journal of clinical investigation.

[12]  Lorin E. Olson,et al.  Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities , 2013, Current Rheumatology Reports.

[13]  J. Warnet,et al.  Hyaluronan Fragments Improve Wound Healing on In Vitro Cutaneous Model through P2X7 Purinoreceptor Basal Activation: Role of Molecular Weight , 2012, PloS one.

[14]  J. Couchman,et al.  An Introduction to Proteoglycans and Their Localization , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  M. Tammi,et al.  Role of UDP-N-Acetylglucosamine (GlcNAc) and O-GlcNAcylation of Hyaluronan Synthase 2 in the Control of Chondroitin Sulfate and Hyaluronan Synthesis* , 2012, The Journal of Biological Chemistry.

[16]  V. Thannickal,et al.  Targeting NOX enzymes in pulmonary fibrosis , 2012, Cellular and Molecular Life Sciences.

[17]  R. Markwald,et al.  8.9 Delivery systems targeting cancer at the level of ECM , 2012 .

[18]  R. Markwald,et al.  8.2 Targeting the tumor microenvironment in cancer progression , 2012 .

[19]  F. Marincola,et al.  Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma , 2011, Proceedings of the National Academy of Sciences.

[20]  P. Stattin,et al.  Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome. , 2011, The American journal of pathology.

[21]  V. Hascall,et al.  Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 , 2011, The Journal of investigative dermatology.

[22]  A. Vasanji,et al.  Pericellular Versican Regulates the Fibroblast-Myofibroblast Transition , 2011, The Journal of Biological Chemistry.

[23]  M. Jadot,et al.  Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase. , 2011, Biochemical and biophysical research communications.

[24]  E. B. Meltzer,et al.  Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44 , 2011, The Journal of experimental medicine.

[25]  R. Markwald,et al.  Hyaluronan–CD44 interactions as potential targets for cancer therapy , 2011, The FEBS journal.

[26]  M. Tammi,et al.  Transcriptional and post‐translational regulation of hyaluronan synthesis , 2011, The FEBS journal.

[27]  M. Zöller CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? , 2011, Nature Reviews Cancer.

[28]  A. Phillips,et al.  Hyaluronan Facilitates Transforming Growth Factor-β1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction , 2011, The Journal of Biological Chemistry.

[29]  M. Zöller,et al.  CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance* , 2011, The Journal of Biological Chemistry.

[30]  V. Hascall,et al.  Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. , 2011, Matrix biology : journal of the International Society for Matrix Biology.

[31]  A. Leask Possible strategies for anti-fibrotic drug intervention in scleroderma , 2011, Journal of Cell Communication and Signaling.

[32]  R. Vaillancourt,et al.  TGFβ2-mediated production of hyaluronan is important for the induction of epicardial cell differentiation and invasion. , 2010, Experimental cell research.

[33]  D. Abraham,et al.  Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. , 2010, The Journal of investigative dermatology.

[34]  Christina K. Chan,et al.  Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse , 2010, Cellular and Molecular Immunology.

[35]  R. Markwald,et al.  Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor* , 2010, The Journal of Biological Chemistry.

[36]  E. Maytin,et al.  Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice. , 2010, The Journal of investigative dermatology.

[37]  S. Campo,et al.  Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. , 2010, Biochimie.

[38]  M. Longaker,et al.  Interaction of Wingless Protein (Wnt), Transforming Growth Factor-&bgr;1, and Hyaluronan Production in Fetal and Postnatal Fibroblasts , 2010, Plastic and reconstructive surgery.

[39]  R. Xing,et al.  Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy. , 2009, Oral diseases.

[40]  E. Maytin,et al.  Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFR. , 2009, The Journal of investigative dermatology.

[41]  Roger R Markwald,et al.  Delivery of CD44 shRNA/Nanoparticles within Cancer Cells , 2009, Journal of Biological Chemistry.

[42]  A. Ghahary,et al.  Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts. , 2009, The Journal of investigative dermatology.

[43]  P. Olczyk,et al.  [Hyaluronan: structure, metabolism, functions, and role in wound healing]. , 2008, Postepy higieny i medycyny doswiadczalnej.

[44]  Neha S. Gandhi,et al.  The Structure of Glycosaminoglycans and their Interactions with Proteins , 2008, Chemical biology & drug design.

[45]  G. Karakiulakis,et al.  Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension , 2008, European Respiratory Journal.

[46]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[47]  M. Trojanowska Role of PDGF in fibrotic diseases and systemic sclerosis. , 2008, Rheumatology.

[48]  E. Carmona,et al.  Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[49]  Byung-Soo Kim,et al.  Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation. , 2008, Journal of biomedical materials research. Part A.

[50]  Ronit Vogt Sionov,et al.  Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. , 2008, Seminars in cancer biology.

[51]  E. Harris,et al.  The Cytoplasmic Domain of the Hyaluronan Receptor for Endocytosis (HARE) Contains Multiple Endocytic Motifs Targeting Coated Pit-mediated Internalization* , 2008, Journal of Biological Chemistry.

[52]  Y. Hannun,et al.  Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma Cells* , 2008, Journal of Biological Chemistry.

[53]  A. Campos,et al.  Assessment and nutritional aspects of wound healing , 2008, Current opinion in clinical nutrition and metabolic care.

[54]  E. Turley,et al.  Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? , 2008, Journal of Cell Science.

[55]  G. Prestwich,et al.  Prevention of peritendinous adhesions using a hyaluronan‐derived hydrogel film following partial‐thickness flexor tendon injury , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[56]  K. Törrönen,et al.  All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes. , 2008, The Journal of investigative dermatology.

[57]  A. Phillips,et al.  Hyaluronan Facilitates Transforming Growth Factor-β1-mediated Fibroblast Proliferation* , 2008, Journal of Biological Chemistry.

[58]  J. Pujol,et al.  Differential effects of hyaluronan and its fragments on fibroblasts: Relation to wound healing , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[59]  Glenn D Prestwich,et al.  Engineering a clinically-useful matrix for cell therapy , 2008, Organogenesis.

[60]  R. Markwald,et al.  Hyaluronan, CD44, and Cyclooxygenase-2 in Colon Cancer , 2008, Connective tissue research.

[61]  P. Noble,et al.  Hyaluronan in tissue injury and repair. , 2007, Annual review of cell and developmental biology.

[62]  E. Balazs,et al.  Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.

[63]  A. Phillips,et al.  Involvement of Hyaluronan in Regulation of Fibroblast Phenotype* , 2007, Journal of Biological Chemistry.

[64]  Yu-Kyoung Oh,et al.  Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[65]  O. Herzberg,et al.  Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. , 2007, Biochemistry.

[66]  David Abraham,et al.  Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.

[67]  M. Takahashi,et al.  CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2* , 2007, Journal of Biological Chemistry.

[68]  S. Ghatak,et al.  Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells* , 2006, Journal of Biological Chemistry.

[69]  W. Knudson,et al.  Acylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis* , 2006, Journal of Biological Chemistry.

[70]  Glenn D Prestwich,et al.  Molecular stenting with a crosslinked hyaluronan derivative inhibits collagen gel contraction. , 2006, The Journal of investigative dermatology.

[71]  Robert Stern,et al.  Hyaluronan fragments: an information-rich system. , 2006, European journal of cell biology.

[72]  George Broughton,et al.  The Basic Science of Wound Healing , 2006, Plastic and reconstructive surgery.

[73]  R. Gallo,et al.  Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  C. A. de la Motte,et al.  Hyaluronan cross-linking: a protective mechanism in inflammation? , 2005, Trends in immunology.

[75]  C. Isacke,et al.  Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding , 2005, Journal of Cell Science.

[76]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[77]  Sabrina Cattaruzza,et al.  Proteoglycan control of cell movement during wound healing and cancer spreading. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[78]  V. Hascall,et al.  Hoxb13 Up-regulates Transglutaminase Activity and Drives Terminal Differentiation in an Epidermal Organotypic Model* , 2005, Journal of Biological Chemistry.

[79]  P. Peplow Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds , 2005, Thrombosis and Haemostasis.

[80]  T. Thatcher,et al.  PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis , 2005 .

[81]  S. Ghatak,et al.  Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2*♦ , 2005, Journal of Biological Chemistry.

[82]  C. Carlberg,et al.  The Human Hyaluronan Synthase 2 Gene Is a Primary Retinoic Acid and Epidermal Growth Factor Responding Gene* , 2005, Journal of Biological Chemistry.

[83]  S. Ghatak,et al.  Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells* , 2005, Journal of Biological Chemistry.

[84]  E. Wouters,et al.  Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation , 2005, Thorax.

[85]  Kristen W. Lynch,et al.  Consequences of regulated pre-mRNA splicing in the immune system , 2004, Nature Reviews Immunology.

[86]  Shi-min Chang,et al.  [Examination of serum hyaluronic acid level in patients with oral and maxillofacial malignancy]. , 2004, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology.

[87]  Yihai Cao,et al.  Impaired Angiogenesis, Delayed Wound Healing and Retarded Tumor Growth in Perlecan Heparan Sulfate-Deficient Mice , 2004, Cancer Research.

[88]  C. A. de la Motte,et al.  Intracellular hyaluronan: a new frontier for inflammation? , 2004, Biochimica et biophysica acta.

[89]  T. Krieg,et al.  Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. , 2004, The American journal of pathology.

[90]  N. Williams,et al.  Identification and Analysis of the Promoter Region of the Human Hyaluronan Synthase 2 Gene* , 2004, Journal of Biological Chemistry.

[91]  A. Barbul,et al.  Understanding the role of immune regulation in wound healing. , 2004, American journal of surgery.

[92]  R. Stern,et al.  Clinical and Laboratory Investigations Aberrant serum hyaluronan and hyaluronidase levels in scleroderma , 2004 .

[93]  Ankush Gosain,et al.  Aging and Wound Healing , 2004, World Journal of Surgery.

[94]  Brown Ja The role of hyaluronic acid in wound healing’s proliferative phase , 2004 .

[95]  K. Törrönen,et al.  Keratinocyte Growth Factor Stimulates Migration and Hyaluronan Synthesis in the Epidermis by Activation of Keratinocyte Hyaluronan Synthases 2 and 3* , 2003, Journal of Biological Chemistry.

[96]  Timothy A. Springer,et al.  Therapeutic antagonists and conformational regulation of integrin function , 2003, Nature Reviews Drug Discovery.

[97]  L. Bourguignon,et al.  Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression* , 2003, Journal of Biological Chemistry.

[98]  S. Ghatak,et al.  Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan* , 2003, Journal of Biological Chemistry.

[99]  V. Hascall,et al.  Hoxb13 knockout adult skin exhibits high levels of hyaluronan and enhanced wound healing , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[100]  Mikko J Lammi,et al.  EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. , 2003, The Journal of investigative dermatology.

[101]  J. Keats,et al.  RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. , 2003, Molecular biology of the cell.

[102]  J. Sleeman,et al.  CD44 is required for two consecutive steps in HGF/c-Met signaling. , 2002, Genes & development.

[103]  M. Stepp,et al.  Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse , 2002, Journal of Cell Science.

[104]  S. Ghatak,et al.  Hyaluronan Oligosaccharides Inhibit Anchorage-independent Growth of Tumor Cells by Suppressing the Phosphoinositide 3-Kinase/Akt Cell Survival Pathway* , 2002, The Journal of Biological Chemistry.

[105]  K. Kimata,et al.  Mammalian Hyaluronan Synthases , 2002, IUBMB life.

[106]  Glenn D Prestwich,et al.  Disulfide cross-linked hyaluronan hydrogels. , 2002, Biomacromolecules.

[107]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[108]  R. Midura,et al.  Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes , 2002, Journal of Cell Science.

[109]  V. Hascall,et al.  Hyaluronan and tumor growth. , 2002, The American journal of pathology.

[110]  S. Klewer,et al.  Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.

[111]  E. Puré,et al.  Resolution of Lung Inflammation by CD44 , 2002, Science.

[112]  V. Hascall,et al.  Hyaluronan Minireview Series* , 2002, The Journal of Biological Chemistry.

[113]  Lilly Y. W. Bourguignon,et al.  Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.

[114]  S. Nedvetzki,et al.  CD44 in Cancer , 2002, Critical reviews in clinical laboratory sciences.

[115]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[116]  L. DiPietro,et al.  Age-related alterations in the inflammatory response to dermal injury. , 2001, The Journal of investigative dermatology.

[117]  M. Tammi,et al.  Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism* , 2001, The Journal of Biological Chemistry.

[118]  Johnny Huard,et al.  The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration * , 2001, The American journal of sports medicine.

[119]  M. Tammi,et al.  Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan* , 2001, The Journal of Biological Chemistry.

[120]  K. Matsumoto,et al.  Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. , 2001, Kidney international.

[121]  C. Soranzo,et al.  Extensive traumatic soft tissue loss: reconstruction in severely injured patients using cultured hyaluronan-based three-dimensional dermal and epidermal autografts. , 2001, The Journal of trauma.

[122]  P. Sime,et al.  Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[123]  T. Mak,et al.  CD44-Deficient Mice Exhibit Enhanced Hepatitis After Concanavalin A Injection: Evidence for Involvement of CD44 in Activation-Induced Cell Death1 , 2001, The Journal of Immunology.

[124]  E. Puré,et al.  A crucial role for CD44 in inflammation. , 2001, Trends in molecular medicine.

[125]  C. Haipek,et al.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. , 2001, Genes & development.

[126]  F. Duh,et al.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[127]  L. Bourguignon,et al.  CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration* , 2001, The Journal of Biological Chemistry.

[128]  M. Detmar,et al.  Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. , 2001, The Journal of clinical investigation.

[129]  R. Cortivo,et al.  In vitro reconstructed dermis implanted in human wounds: degradation studies of the HA-based supporting scaffold. , 2000, Biomaterials.

[130]  A. Spicer,et al.  Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.

[131]  S. Klewer,et al.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.

[132]  I. Campbell,et al.  Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. , 2000, Structure.

[133]  J. Albina,et al.  Macrophage-Induced Neutrophil Apoptosis1 , 2000, The Journal of Immunology.

[134]  E. Puré,et al.  Oncostatin M and Transforming Growth Factor-β1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells* , 2000, The Journal of Biological Chemistry.

[135]  S. Kohno,et al.  Expression of CD44 Variants in Lung Cancer and Its Relationship to Hyaluronan Binding , 2000, The Journal of international medical research.

[136]  L. Bourguignon,et al.  CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration* , 2000, The Journal of Biological Chemistry.

[137]  K. Prydz,et al.  Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.

[138]  F. Hilberg,et al.  CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. , 1999, Journal of immunology.

[139]  T. Hardingham,et al.  The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. , 1999, Biophysical journal.

[140]  S. Scherer,et al.  Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. , 1999, Genomics.

[141]  P. Lenas,et al.  Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties* , 1999, The Journal of Biological Chemistry.

[142]  T. Mak,et al.  Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. , 1999, Journal of immunology.

[143]  G. Abatangelo,et al.  Functions of hyaluronan in wound repair , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[144]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[145]  A. Maiti,et al.  TNF-α Induction of CD44-Mediated Leukocyte Adhesion by Sulfation , 1998 .

[146]  R. Wüthrich,et al.  Mechanisms of Hyaluronan-Induced Up-Regulation of ICAM-1 and VCAM-1 Expression by Murine Kidney Tubular Epithelial Cells: Hyaluronan Triggers Cell Adhesion Molecule Expression Through a Mechanism Involving Activation of Nuclear Factor-κB and Activating Protein-1 , 1998, The Journal of Immunology.

[147]  J. Plouët,et al.  Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. , 1998, Biology of the cell.

[148]  G. Kreil,et al.  HYAL2, a Human Gene Expressed in Many Cells, Encodes a Lysosomal Hyaluronidase with a Novel Type of Specificity* , 1998, The Journal of Biological Chemistry.

[149]  S. Kumar,et al.  Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[150]  P. Johnson,et al.  Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate. , 1998, Journal of cell science.

[151]  I. Stamenkovic,et al.  Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan , 1998, The Journal of cell biology.

[152]  R. Stern,et al.  Purification and microsequencing of hyaluronidase isozymes from human urine , 1997, FEBS letters.

[153]  B. Toole,et al.  Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.

[154]  D. West,et al.  Serum hyaluronan levels follow disease activity in vasculitis. , 1997, Clinical nephrology.

[155]  D. Naor,et al.  Hyaluronan‐independent lodgment of CD44+ lymphoma cells in lymphoid organs , 1997, International journal of cancer.

[156]  J. Banyard,et al.  Differential response of fetal and adult fibroblasts to cytokines: cell migration and hyaluronan synthesis. , 1997, Development.

[157]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[158]  K. Weber,et al.  Tissue repair and angiotensin II generated at sites of healing , 1997, Basic Research in Cardiology.

[159]  M. Horton,et al.  Hyaluronan Fragments Induce Nitric-oxide Synthase in Murine Macrophages through a Nuclear Factor κB-dependent Mechanism* , 1997, The Journal of Biological Chemistry.

[160]  J. Hogg,et al.  Proteoglycan deposition in pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.

[161]  M. Burdick,et al.  Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. , 1996, The Journal of clinical investigation.

[162]  I. Ellis,et al.  Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing. , 1996, Experimental cell research.

[163]  I. Campbell,et al.  Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration , 1996, Cell.

[164]  J. Sleeman,et al.  Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. , 1996, Cancer research.

[165]  E. Turley,et al.  HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.

[166]  K. Burridge,et al.  Rho-stimulated contractility drives the formation of stress fibers and focal adhesions , 1996, The Journal of cell biology.

[167]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[168]  M. Levesque,et al.  In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. , 1996, Journal of immunology.

[169]  Mark Eastwood,et al.  Quantitative analysis of collagen gel contractile forces generated by dermal fibroblasts and the relationship to cell morphology , 1996, Journal of cellular physiology.

[170]  G. Kreil Hyaluronidases — a group of neglected enzymes , 1995, Protein science : a publication of the Protein Society.

[171]  W. Kenney,et al.  Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. , 1995, The Journal of clinical investigation.

[172]  M. Longaker,et al.  The in vivo effect of hyaluronan associated protein-collagen complex on wound repair. , 1995, Biochemistry and molecular biology international.

[173]  A. Perschl,et al.  Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation , 1995, The Journal of experimental medicine.

[174]  K. Oritani,et al.  Glycosylation of CD44 negatively regulates its recognition of hyaluronan , 1995, The Journal of experimental medicine.

[175]  D. Foreman,et al.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.

[176]  E. Puré,et al.  Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain , 1995, The Journal of experimental medicine.

[177]  R. D. du Bois,et al.  Insulin-like growth factor-I is partially responsible for fibroblast proliferation induced by bronchoalveolar lavage fluid from patients with systemic sclerosis. , 1994, Clinical science.

[178]  I. K. Cohen,et al.  Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. , 1993, Matrix.

[179]  F M van den Berg,et al.  Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. , 1993, Cancer research.

[180]  W. Knudson,et al.  Hyaluronan‐binding proteins in development, tissue homeostasis, and disease , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[181]  M. Anscher,et al.  Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .

[182]  P. Herrlich,et al.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.

[183]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[184]  Kahaleh Mb Nerve root pain secondary to posterior articular cysts: a report of 6 cases and review of the literature. , 1992 .

[185]  E. Turley,et al.  Hyaluronan and cell locomotion , 1992, Cancer and Metastasis Reviews.

[186]  M. Laato,et al.  Induced expression of syndecan in healing wounds , 1991, The Journal of cell biology.

[187]  G. Prestwich,et al.  Chemical modification of hyaluronic acid by carbodiimides. , 1991, Bioconjugate chemistry.

[188]  M. Ferguson,et al.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice. , 1991, Development.

[189]  B. Delpech,et al.  Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis , 1991, The British journal of dermatology.

[190]  M. Longaker,et al.  Studies in Fetal Wound Healing V. A Prolonged Presence of Hyaluronic Acid Characterizes Fetal Wound Fluid , 1991, Annals of surgery.

[191]  E. Turley,et al.  Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells , 1991, The Journal of cell biology.

[192]  M. Longaker Studies in fetal wound healing: II , 1991 .

[193]  A. Abbas,et al.  Cellular and Molecular Immunology , 1991 .

[194]  G. Laurent,et al.  The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. , 1991, Biochimica et biophysica acta.

[195]  B. Asselain,et al.  Serum hyaluronan (hyaluronic acid) in breast cancer patients , 1990, International journal of cancer.

[196]  R. Derynck,et al.  Transforming growth factor‐α , 1990, Molecular reproduction and development.

[197]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[198]  F. Barry Proteoglycans: structure and function. , 1990, Biochemical Society transactions.

[199]  M. Sporn,et al.  Transforming growth factor-beta: multifunctional regulator of differentiation and development. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[200]  R. Hällgren,et al.  Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. , 1989, The American review of respiratory disease.

[201]  R. Spendlove,et al.  Studies in fetal wound healing: I. A factor in fetal serum that stimulates deposition of hyaluronic acid. , 1989, Journal of pediatric surgery.

[202]  L. Nanney,et al.  Enhancement of wound healing by topical treatment with epidermal growth factor. , 1989, The New England journal of medicine.

[203]  Thomas A. Mustoe, MD, FACS,et al.  Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms , 1989, The Journal of cell biology.

[204]  C. Heldin,et al.  Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. , 1989, The Biochemical journal.

[205]  Edward Y Lee,et al.  Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[206]  P. Pilch,et al.  Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. , 1989, Endocrinology.

[207]  R. Crystal,et al.  Alveolar macrophages release an insulin-like growth factor I-type molecule. , 1988, The Journal of clinical investigation.

[208]  T. Springer,et al.  ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells , 1988, Nature.

[209]  R. Colvin,et al.  Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[210]  E. Vuorio,et al.  Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. , 1987, The Biochemical journal.

[211]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[212]  S. Hellström,et al.  Hyaluronic acid reduces connective tissue formation in middle ears filled with absorbable gelatin sponge: an experimental study. , 1986, American journal of otolaryngology.

[213]  W. H. Betts,et al.  Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. , 1985, Annals of the rheumatic diseases.

[214]  I. Hampson,et al.  Angiogenesis induced by degradation products of hyaluronic acid. , 1985, Science.

[215]  G. Abatangelo,et al.  Healing of hyaluronic acid-enriched wounds: histological observations. , 1983, The Journal of surgical research.

[216]  M J Bissell,et al.  How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.

[217]  R. Clark,et al.  Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. , 1982, The Journal of investigative dermatology.

[218]  L. Culp,et al.  Glycosaminoglycans that bind cold-insoluble globulin in cell-substratum adhesion sites of murine fibroblasts. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[219]  B. Bhaumick,et al.  Release of somatomedin-like activity by cultured WI-38 human fibroblasts. , 1980, Endocrinology.

[220]  E Bell,et al.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[221]  H. Green,et al.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.

[222]  R. Stephenson A and V , 1962, The British journal of ophthalmology.

[223]  Hugh Gordon,et al.  Scleroderma , 1937 .

[224]  Karl Meyer,et al.  THE POLYSACCHARIDE OF THE VITREOUS HUMOR , 1934 .

[225]  W. Marsden I and J , 2012 .

[226]  P. Heldin Growth factor regulation of hyaluronan metabolism in tumor progression , 2009 .

[227]  Oliver Distler,et al.  Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. , 2009, Arthritis and rheumatism.

[228]  Glenn D Prestwich,et al.  Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. , 2008, Accounts of chemical research.

[229]  Oliver Distler,et al.  Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. , 2007, Arthritis and rheumatism.

[230]  R. Savani,et al.  Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[231]  Tarynn M Witten,et al.  Impaired wound healing. , 2007, Clinics in dermatology.

[232]  S. Ghatak,et al.  REGULATION OF MDR 1 EXPRESSION AND DRUG RESISTANCE BY A POSITIVE FEEDBACK LOOP INVOLVING HYALURONAN , PHOSPHOINOSITIDE 3-KINASE AND ERBB 2 * , 2005 .

[233]  J. Brown The role of hyaluronic acid in wound healing's proliferative phase. , 2004, Journal of wound care.

[234]  A. Cantin,et al.  Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep , 2004, Lung.

[235]  T. S. Wilkinson,et al.  Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. , 2004, American journal of respiratory cell and molecular biology.

[236]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[237]  P. Noble Hyaluronan and its catabolic products in tissue injury and repair. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[238]  V. Hascall,et al.  POLY I:C INDUCES MONONUCLEAR LEUKOCYTE-ADHESIVE HYALURONAN STRUCTURES ON COLON SMOOTH MUSCLE CELLS: IαI AND VERSICAN FACILITATE ADHESION , 2002 .

[239]  V. Assmann,et al.  CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. , 2001, The Journal of investigative dermatology.

[240]  T. Ishida Immunohistochemical Expression of the CD44 Variant 6 in Colorectal Adenocarcinoma , 2000, Surgery Today.

[241]  G. Offerhaus,et al.  CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value , 1999 .

[242]  A. Reiner,et al.  CD44 expression in benign and malignant colorectal polyps , 1999, Diseases of the colon and rectum.

[243]  I. Stamenkovic,et al.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.

[244]  R. Clark,et al.  Overview and General Considerations of Wound Repair , 1998 .

[245]  P. Johnson,et al.  TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. , 1998, Science.

[246]  M. Mohamadzadeh,et al.  Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. , 1998, The Journal of clinical investigation.

[247]  C. van Krimpen,et al.  CD44 splice variants as prognostic markers in colorectal cancer. , 1998, Scandinavian journal of gastroenterology.

[248]  J. Iredale Tissue inhibitors of metalloproteinases in liver fibrosis. , 1997, The international journal of biochemistry & cell biology.

[249]  M. Longaker,et al.  Fibrotic healing of adult and late gestation fetal wounds correlates with increased hyaluronidase activity and removal of hyaluronan. , 1997, The international journal of biochemistry & cell biology.

[250]  G. Laurent,et al.  The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? , 1997, The international journal of biochemistry & cell biology.

[251]  T. Franklin Therapeutic approaches to organ fibrosis. , 1997, The international journal of biochemistry & cell biology.

[252]  K. Weber,et al.  Myofibroblasts and local angiotensin II in rat cardiac tissue repair. , 1997, The international journal of biochemistry & cell biology.

[253]  S. Kamata,et al.  Hyaluronic acid of wound fluid in adult and fetal rabbits. , 1997, Journal of pediatric surgery.

[254]  M Tammi,et al.  Hyaluronan synthases. , 1997, The Journal of biological chemistry.

[255]  A. E. El Nahas,et al.  Renal fibrosis: insights into pathogenesis and treatment. , 1997, The international journal of biochemistry & cell biology.

[256]  Ronit Vogt Sionov,et al.  CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.

[257]  K. Burridge,et al.  Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.

[258]  I. Emerit,et al.  Hyaluronic acid in progressive systemic sclerosis. , 1996, Dermatology.

[259]  R L Bartel,et al.  Characterization, barrier function, and drug metabolism of an in vitro skin model. , 1993, The Journal of investigative dermatology.

[260]  M. Anscher,et al.  Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. , 1993, The New England journal of medicine.

[261]  M. Nakamura,et al.  Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan. , 1992, Current eye research.

[262]  M. Kahaleh The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy). , 1992, Clinical and Experimental Rheumatology.

[263]  W. Hickerson,et al.  Beneficial actions of exogenous hyaluronic acid on wound healing. , 1991, Surgery.

[264]  M. Longaker,et al.  Hyaluronan and wound healing: a new perspective. , 1991, British journal of plastic surgery.

[265]  M. Marazzi,et al.  Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats. , 1990, International journal of tissue reactions.

[266]  M. Sporn,et al.  Transforming growth factor-beta. Major role in regulation of extracellular matrix. , 1990, Annals of the New York Academy of Sciences.

[267]  M. Sporn,et al.  Transforming Growth Factor , 1990 .

[268]  S. Kumar,et al.  Hyaluronan and angiogenesis. , 1989, Ciba Foundation symposium.

[269]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[270]  J. Garland The New England Journal of Medicine. , 1961, Canadian Medical Association journal.

[271]  F. Segal,et al.  A CHARACTERIZATION OF FIBRANT SEGAL CATEGORIES , 2006, math/0603400.